AAV2-hRPE65v2,voretigene neparvovec-rzyl for retinitis pigmentosa

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Oct 2009: Trial registered, NCT00999609

The trials

NCT00999609: Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

State
Under way
Phase
Phase 3
People
31 taking part
Started
Oct 2012
Primary completion
Jul 2015
Arms
AAV2-hRPE65v2,voretigene neparvovec-rzyl
Results
Posted on the registry
  1. 22 Oct 2009: Trial registered
  2. 26 Mar 2018: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.